Dupilumab and omalizumab are both effective adjuvant treatments for adults with bullous pemphigoid, though dupilumab may ...

Upon beginning Stage 2, all participants received injections of omalizumab for eight weeks. Then the participants were ...

which is sold as Xolair, has shown that it can successfully treat seasonal allergies in preliminary clinical trials. Administered as a single injection, it represents a type of treatment using lab ...

On World Asthma Day, a suburban family is sounding the alarm on how an insurance change could impact life-saving care for their daughter.

Last week, Celltrion USA announced it had submitted a BLA for CT-P39, a biosimilar to XOLAIR (omalizumab). Phase 3 studies demonstrated that in patients with chronic spontaneous urticaria ...

JERSEY CITY, N.J., March 10, 2025 /PRNewswire/ -- Celltrion today announced the U.S. Food and Drug Administration (FDA) approved OMLYCLO ® (omalizumab-igec) as the first and only biosimilar designated ...

Objectives: To describe allergic asthma and allergic rhinitis pathophysiology and review the pharmacologic, pharmacokinetic, pharmacodynamic, efficacy, and safety data for omalizumab. Methods ...